Literature DB >> 16895968

Non-muscle myosins 2A and 2B drive changes in cell morphology that occur as myoblasts align and fuse.

Nathan T Swailes1, Melanie Colegrave, Peter J Knight, Michelle Peckham.   

Abstract

The interaction of non-muscle myosins 2A and 2B with actin may drive changes in cell movement, shape and adhesion. To investigate this, we used cultured myoblasts as a model system. These cells characteristically change shape from triangular to bipolar when they form groups of aligned cells. Antisense oligonucleotide knockdown of non-muscle myosin 2A, but not non-muscle myosin 2B, inhibited this shape change, interfered with cell-cell adhesion, had a minor effect on tail retraction and prevented myoblast fusion. By contrast, non-muscle myosin 2B knockdown markedly inhibited tail retraction, increasing cell length by over 200% by 72 hours compared with controls. In addition it interfered with nuclei redistribution in myotubes. Non-muscle myosin 2C is not involved as western analysis showed that it is not expressed in myoblasts, but only in myotubes. To understand why non-muscle myosins 2A and 2B have such different roles, we analysed their distributions by immuno-electron microscopy, and found that non-muscle myosin 2A was more tightly associated with the plasma membrane than non-muscle myosin 2B. This suggests that non-muscle myosin 2A is more important for bipolar shape formation and adhesion owing to its preferential interaction with membrane-associated actin, whereas the role of non-muscle myosin 2B in retraction prevents over-elongation of myoblasts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16895968     DOI: 10.1242/jcs.03096

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  34 in total

1.  S100P dissociates myosin IIA filaments and focal adhesion sites to reduce cell adhesion and enhance cell migration.

Authors:  Min Du; Guozheng Wang; Thamir M Ismail; Stephane Gross; David G Fernig; Roger Barraclough; Philip S Rudland
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

Review 2.  Moving and positioning the nucleus in skeletal muscle - one step at a time.

Authors:  Bruno Cadot; Vincent Gache; Edgar R Gomes
Journal:  Nucleus       Date:  2015       Impact factor: 4.197

Review 3.  Myoblast fusion: lessons from flies and mice.

Authors:  Susan M Abmayr; Grace K Pavlath
Journal:  Development       Date:  2012-02       Impact factor: 6.868

4.  Regulated proteolysis of nonmuscle myosin IIA stimulates osteoclast fusion.

Authors:  Brooke K McMichael; Robert B Wysolmerski; Beth S Lee
Journal:  J Biol Chem       Date:  2009-03-05       Impact factor: 5.157

5.  Nap1-mediated actin remodeling is essential for mammalian myoblast fusion.

Authors:  Scott J Nowak; Patrick C Nahirney; Anna-Katerina Hadjantonakis; Mary K Baylies
Journal:  J Cell Sci       Date:  2009-08-25       Impact factor: 5.285

6.  Localization of sarcomeric proteins during myofibril assembly in cultured mouse primary skeletal myotubes.

Authors:  Jennifer White; Marietta V Barro; Helen P Makarenkova; Joseph W Sanger; Jean M Sanger
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

Review 7.  Regulatory Roles of Fluctuation-Driven Mechanotransduction in Cell Function.

Authors:  Béla Suki; Harikrishnan Parameswaran; Jasmin Imsirovic; Erzsébet Bartolák-Suki
Journal:  Physiology (Bethesda)       Date:  2016-09

8.  Block the function of nonmuscle myosin II by blebbistatin induces zebrafish embryo cardia bifida.

Authors:  Xueqian Wang; Mei Chong; Xin Wang; Hongkui Wang; Jie Zhang; Hui Xu; Jingjing Zhang; Dong Liu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-11-18       Impact factor: 2.416

Review 9.  Mechanical control of tissue morphogenesis.

Authors:  Parth Patwari; Richard T Lee
Journal:  Circ Res       Date:  2008-08-01       Impact factor: 17.367

10.  P-cadherin counteracts myosin II-B function: implications in melanoma progression.

Authors:  Koen Jacobs; Mireille Van Gele; Ramses Forsyth; Lieve Brochez; Barbara Vanhoecke; Olivier De Wever; Marc Bracke
Journal:  Mol Cancer       Date:  2010-09-22       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.